Dr. Woo is a consultant gynaecological oncologist with clinical and research experience that ranges from prevention to treatment of cervical cancer and hereditary/ familial gynaecological cancers. She undertook her research in HPV immune-biology in the University of Cambridge under the Cancer Research UK Gordon Hamilton Fairley Fellowship and was awarded a PhD degree in 2008. As a clinician, she was awarded the gold medal by the Royal College of Obstetrician and Gynaecologist as the top ranked individual for the international examination. Having trained and worked in the UK, she returned to Malaysia in 2010 to take up a professorial post in the premier teaching hospital, University Malaya (UM). As a translational scientist, she has worked tirelessly to making this knowledge more accessible and applicable to the broader population through her advisory role on policy development nationally and internationally. She is also a recognized expert in HPV vaccination and is currently the country representative (Malaysia) for the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN), taskforce member for the Malaysian policy change to Primary HPV screening for cervical cancer, member of the Asia Pacific Economic Consortium (APEC) Cervical Cancer working group and is the founding principal investigator for Program ROSE (Removing Obstacles to cervical ScrEening, a revolutionary approach to cervical cancer screening. Program ROSE (www.programrose.org, @programROSE) that utilizes digital technology, self-sampling and HPV testing. The program was recently highlighted by the Economist Intelligence Unit (https://eiuperspectives.economist.com/healthcare/global-action-financing-cervical-cancer-elimination-funding-secondary-prevention-services-low). The program was a strong contender at the 2018 UICC Collaborative award, shortlisted among 2 other nominations globally, and has received many international accolades and praises. Program ROSE (www.programrose.org, @programROSE) utilizes digital technology, self-sampling and HPV testing to change the paradigm of conventional cervical screening, facilitating increased screening uptake for ALL woman. Dr Woo is also the founder of ROSE Foundation, a non-profit organisation, dedicated to making cervical cancer prevention accessible and affordable to the underprivileged. The success of Program ROSE is a testament to her incessant drive to make cervical cancer a rare disease in our lifetime. She also dedicates her time to working closely with other academic institutions, NGOS and also industry to educate, inform and advise on matters pertaining to control of HPV associated diseases. In recognition for her contribution to women's health, Dr. Woo was conferred the FIGO Awards in recognition of Female Obstetrician and Gynaecologist in 2021.